At just 26 years old, Leah Adams heard the words no one wants to hear: malignant melanoma. In this powerful and emotional story, Leah shares how a routine skin check —prompted by her mother's intuition—led to a life-altering diagnosis. As a runner and only child, Leah's journey through surgery, recovery, and her father's parallel battle with stage 4 metastatic melanoma sheds light on how deeply this disease can impact families. Watch as Leah explains how the DecisionDx® Melanoma test helped guide her next s ...

WATERTOWN, Mass., May 07, 2025 (GLOBE NEWSWIRE) -- Lyra Therapeutics, Inc. (Nasdaq: LYRA), ("Lyra" or the "Company"), a clinical-stage biotechnology company developing long-acting, anti-inflammatory sinonasal implants for the treatment of chronic rhinosinusitis (CRS), today announced that the Company plans to present results from the 52-week Extension Stage of the ENLIGHTEN 1 Phase 3 study for LYR-210, the Company's lead product candidate for CRS, at the annual Combined Otolaryngology Spring Meetings (COSM ...

Updated Cemsidomide Multiple Myeloma Data Further Demonstrate Compelling Response Rates at Multiple Doses and Potential for Best-in-Class Profile; 50% ORR Observed at the Highest Dose Level of 100 µg, Including One Patient With a Minimal Residual Disease Negative Complete Response; 40% ORR Achieved at the 75 µg Dose Level Cemsidomide Multiple Myeloma Dose Escalation is Complete; FDA Feedback Expected by Mid-Year 2025 to Support Initiation of Next Phase of Development in Early 2026 Portfolio Decision to Prio ...

Core Insights - Kymera Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing oral small molecule degrader medicines for immunological diseases [1][3] - The company will participate in a fireside chat at the BofA Securities 2025 Healthcare Conference on May 14, 2025 [1] - A live webcast of the presentation will be available on the company's website, with a replay archived post-event [2] Company Overview - Kymera Therapeutics is pioneering targeted protein degradation (TPD) to create medicines for critical health issues, aiming to improve patient outcomes significantly [3] - The company has advanced its first degrader into clinical trials for immunological diseases and is building a robust pipeline of oral small molecule degraders [3] - Founded in 2016, Kymera has been recognized as one of Boston's top workplaces in recent years [3] Communication and Information Availability - Kymera encourages investors and the public to review information posted on its website and social media platforms, which may contain material information [4] - The company utilizes its website for corporate disclosures, investor presentations, SEC filings, and press releases [4]

SHANGHAI, China, May 07, 2025 (GLOBE NEWSWIRE) -- GDS Holdings Limited ("GDS Holdings", "GDS" or the "Company") (NASDAQ: GDS; HKEX: 9698), a leading developer and operator of high- performance data centers in China, today announced that it will report its first quarter 2025 unaudited financial results after the close of the Hong Kong market and before the open of the U.S. market on May 20, 2025. About GDS Holdings Limited GDS Holdings Limited (NASDAQ: GDS; HKEX: 9698) is a leading developer and operator of ...

TORONTO, May 07, 2025 (GLOBE NEWSWIRE) -- Sprott Inc. (NYSE/TSX: SII) ("Sprott" or the "Company") today announced its financial results for the quarter ended March 31, 2025. Management commentary "Sprott's Assets Under Management ("AUM") ended the first quarter of 2025 at $35.1 billion, up 11% from $31.5 billion as at December 31, 2024," said Whitney George, Chief Executive Officer of Sprott. "Our AUM growth during the quarter was driven by surging gold prices and strong inflows to our physical gold and sil ...

TORONTO, May 07, 2025 (GLOBE NEWSWIRE) -- Northland Power Inc. ("Northland" or the "Company") (TSX: NPI) is pleased to announce that the Oneida Energy Storage Project ("Oneida") has successfully commenced commercial operations. The project was completed ahead of schedule and under budget and is the largest battery energy storage facility in operation in Canada. "Today marks a major milestone for Northland and the Oneida project," said Christine Healy, President & Chief Executive Officer of Northland. "Oneid ...

• Non-Dilutive Financing • Up to US$10 Million Promissory Note Provided by Vantive • If Fully Drawn, Promissory Note is Expected to Fully Fund Spectral to PMX Commercialization • Company to host Corporate Update Call on May 15, 2025 TORONTO, May 07, 2025 (GLOBE NEWSWIRE) -- Spectral Medical Inc. ("Spectral" or the "Company") (TSX: EDT), a late-stage theranostic company advancing therapeutic options for sepsis and septic shock, today announced that it has entered into a senior secured promissory note (the "A ...

Announces Completion of Acquisition of Kurt GeigerLONG ISLAND CITY, N.Y., May 07, 2025 (GLOBE NEWSWIRE) -- Steven Madden, Ltd. (Nasdaq: SHOO), a leading designer and marketer of fashion-forward footwear, accessories and apparel, today announced financial results for the first quarter ended March 31, 2025. Amounts referred to as “Adjusted” are non-GAAP measures that exclude the items defined as “Non-GAAP Adjustments” in the “Non-GAAP Reconciliation” section. First Quarter 2025 Results Revenue increased 0.2% ...

Hong Kong, China, May 07, 2025 (GLOBE NEWSWIRE) -- On May 1, 2025, Hong Kong ——, a leading logistics solutions provider in Hong Kong, New Century Logistics (BVI) Limited (hereinafter referred to as "New Century") announced today that it has signed a Memorandum of Understanding (MOU) with Japanese advanced technology company Soradynamics Inc to jointly develop and deploy an innovative in-vehicle drone logistics system ("Micro-Hub System"). This collaboration aims to address the long-standing core pain points ...